| 查看: 1395 | 回复: 3 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
zhangchong2303金虫 (小有名气)
|
[求助]
阿洛夫定（alovudine）新药临床几期？
|
||
|
求助各位大侠，我想查询一下阿洛夫定（alovudine）新药临床到几期。一下我是美国的clinicaltrial上面查到的信息，看不懂是几期怎么判断。 Found 14 studies with search of: Alovudine Hide studies that are not seeking new volunteers. Hide studies with unknown recruitment status. Display Options Rank Status Study 1 Completed An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 2 Completed An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 3 Completed A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) Condition: HIV Infections Intervention: Drug: Alovudine 4 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3'-Deoxy-3'-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition: Neuroblastoma Intervention: Device: FLT-PET 5 Recruiting Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) Conditions: High-grade Glioma; Astrocytoma; Glioblastoma Intervention: Radiation: 18F Fluorothymidine PET CT 6 Recruiting Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors Condition: Breast Cancer Interventions: Drug: BMS-754807; Drug: letrozole 7 Recruiting A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Conditions: Cancer; Solid Tumor; Lymphoma Intervention: Biological: 18F-FLT 8 Recruiting Image-Guided Stereotactic Biopsy of High Grade Gliomas Conditions: Brain Cancer; Glioma Intervention: Procedure: 18F-FLT PET Scan 9 Completed 18F-FLT-PET in Breast Cancer (MK-0000-139 AM1) Condition: Breast Cancer Intervention: Procedure: 18F-FLT-Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging 10 Recruiting Pilot Study of 18F-FLT PET Conditions: CNS Brain Metastasis; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Esophageal Cancer Intervention: Procedure: Imaging with 18F-FLT PET 11 Terminated A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors Condition: Tumors of the Central Nervous System Intervention: Other: [18F]-Fluorothymidine 12 Recruiting An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine Condition: Pancreatic Cancer Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT 13 Recruiting Validation of 18F-MISO-PET and 18F-FLT-PET Condition: Head and Neck Neoplasms Intervention: Procedure: 18F-FLT and 18F-MISO-PET 14 Recruiting Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors Condition: Lung Cancer Intervention: 求解释，非常感谢 |
回复此楼» 收录本帖的淘帖专辑推荐
 新药发现 |
» 猜你喜欢
[学习资料分享] FAERS数据库的不良反应挖掘(频数法/贝叶斯法)
已经有1人回复
-
招收医学、基础医学类调剂研究生
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有266人回复
-
是否属于脾肾阳虚证
已经有0人回复
-
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
2026年申博药学专业
已经有1人回复
-
292药学调剂
已经有1人回复
-
广西医科大学基础医学院自身免疫病课题组招收基础医学相关专业的调剂研究生
已经有2人回复
-
药学专硕申博
已经有1人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- Nat Biotech：2003-2011年新药临床研究成功率分析报告
已经有6人回复
- 国外新药，已经进入Ⅱ期临床研究的新药进展情况如何查询？？？
已经有6人回复
- 中药新药临床前研究药学研究资料要注意什么才能提高通过率
已经有3人回复
- 申报中药新药临床批件到省局时的现场考核要注意什么？
已经有4人回复
- 申请新药临床，已发批件，是否就是被批准临床？
已经有10人回复
- 三期临床，真的很难
已经有17人回复
- 【求助】请问新药临床试验的申报资料在哪里可以查到啊？
已经有7人回复
- 【求助】中药新药临床研究指导原则第二辑 1993版
已经有12人回复
- 【求助】新药临床前研究包括那些内容
已经有6人回复
nkbeholder
木虫 (正式写手)
- DRDEPI: 1
- 应助: 11 (小学生)
- 金币: 2945.1
- 散金: 4
- 红花: 5
- 帖子: 748
- 在线: 303.7小时
- 虫号: 202353
- 注册: 2006-03-01
- 性别: GG
- 专业: 药物化学
3楼2012-02-02 13:49:56
nkbeholder
木虫 (正式写手)
- DRDEPI: 1
- 应助: 11 (小学生)
- 金币: 2945.1
- 散金: 4
- 红花: 5
- 帖子: 748
- 在线: 303.7小时
- 虫号: 202353
- 注册: 2006-03-01
- 性别: GG
- 专业: 药物化学
【答案】应助回帖
★
感谢参与，应助指数 +1
lk590(金币+1): 谢谢参与 2012-02-02 11:31:54
zhangchong2303(金币+10): ★★★很有帮助 谢谢，从这上面看应该是临床2期，是吗？ 2012-02-02 13:47:37
感谢参与，应助指数 +1
lk590(金币+1): 谢谢参与 2012-02-02 11:31:54
zhangchong2303(金币+10): ★★★很有帮助 谢谢，从这上面看应该是临床2期，是吗？ 2012-02-02 13:47:37
|
dialog上的信息，更新到2007年 Originator Company: Medivir AB (Sweden) Parent Company: Medivir AB Licensee: Beijing Mefuvir Medicinal Technology Highest Phase: Discontinued II Development Status: Discontinued II, France, HIV infections treatment Discontinued II, Sweden, HIV infections treatment Discontinued II, USA, HIV infections treatment |
2楼2012-02-02 11:28:31
iamzane
至尊木虫 (著名写手)
- 应助: 129 (高中生)
- 贵宾: 0.7
- 金币: 24630.1
- 散金: 40
- 红花: 21
- 帖子: 1974
- 在线: 459.5小时
- 虫号: 330866
- 注册: 2007-03-24
- 专业: 药物学其他科学问题
4楼2012-02-02 13:53:25
